IV Vitamin C May Improve Trauma Patient Outcomes

A review of existing evidence suggests that high-dose intravenous (IV) vitamin C may reduce mortality, sepsis risk, and hospitalization duration in trauma patients, according to a study published in *BMJ Military Health*. The analysis, which synthesizes findings from multiple clinical trials and observational studies, highlights the potential of vitamin C as an adjunct therapy in critical care settings, particularly for patients with severe injuries or those at risk of post-traumatic complications.

The review, conducted by researchers from the University of Maryland School of Medicine and the Uniformed Services University of the Health Sciences, examined data from trauma patients receiving IV vitamin C in doses ranging from 1 to 3 grams daily. Results indicated a 40% reduction in sepsis incidence and a 30% decrease in mortality compared to standard care groups. Additionally, patients treated with high-dose vitamin C spent an average of three fewer days in the hospital. While the mechanisms remain unclear, researchers speculate that vitamin C’s antioxidant properties may mitigate oxidative stress and inflammation, common in trauma and sepsis. The authors caution that further randomized controlled trials are needed to confirm these findings and establish standardized protocols.

If validated, the findings could influence clinical guidelines for trauma management, offering a low-cost, accessible intervention to improve outcomes. However, experts emphasize the importance of balancing enthusiasm with caution, given the current evidence base and the need for larger, more rigorous studies to confirm efficacy and safety in diverse patient populations. The study underscores the growing interest in repurposing existing therapies for critical care applications.